跳至主要内容
临床试验/NCT07622966
NCT07622966已完成不适用

A Molecular Approach to Examining the Immune Stimulatory Impact of Lymphatic Pump Technique in Healthy Patients; A Pilot Study

Edward Via Virginia College of Osteopathic Medicine1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2025年1月10日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1

研究概览

简要总结

The goal of this clinical trial is to learn if osteopathic manipulative treatment (OMT) changes levels of immune markers in healthy volunteers. The main questions it aims to answer are:

Does OMT change numbers of white blood cells or antibodies? Does OMT change levels of cytokines?

Researchers will compare volunteers treated with OMT to volunteers undergoing sham treatment to see if OMT changes levels of immune markers.

Participants will:

  • complete a survey about their medical history to determine if they are healthy enough for OMT
  • have blood drawn
  • undergo either sham treatment or OMT
  • have blood drawn 30 minutes after treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects are healthy; have independently read, understood, and without coercion signed the consent form; agree to allow for samples to be taken; agree to fill out all the documentation and surveys; and identifies as any race(s), ethnicity(ies), and/or gender(s)

排除标准

  • subjects present at initial visit with a fever greater than 100.5 °F; have participated in a clinical trial within the last 6 months; work night shifts; who are immunocompromised including: HIV+, have had cancers, or are pregnant or nursing; have current bone fractures of the head and neck; history of osteoporosis, acute hepatitis, deep vein thrombosis, pulmonary embolism, trauma to the liver or spleen, surgery in the past 6 months or necrotizing fasciitis. Other relative contraindications to receiving OMT include doderate to severe cardiac conditions, moderate to severe congestive heart failure, infectious mononucleosis, chronic abscesses or osteomyelitis, coagulopathies or patients on anticoagulants, COPD, and acute indurated lymph node

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rebekah Morrow

Discipline Chair for Immunology and Microbiology

Edward Via Virginia College of Osteopathic Medicine

研究点 (1)

Loading locations...

相似试验